![Matthew Bartholomae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Matthew Bartholomae is Secretary & General Counsel at Cartesian Therapeutics, Inc. since 2023.
Formerly, Secretary & General Counsel at Selecta Biosciences, Inc. from 2020 to 2023, and Counsel at Minerva Neurosciences, Inc. from 2016 to 2018.
Education includes undergraduate studies at Boston College and graduate studies at the University of New Hampshire School of Law.
Posizioni attive di Matthew Bartholomae
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Matthew Bartholomae
| Società | Posizione | Fine |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Consigliere Generale | 01/11/2023 |
| MINERVA NEUROSCIENCES, INC. | Corporate Officer/Principal | 01/01/2018 |
Formazione di Matthew Bartholomae
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
16
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
University of New Hampshire School of Law
 University of New Hampshire School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
